1. Genentech wants to double its San Francisco footprint — Biotechs with the biggest cash piles — Purdue Pharma wants to pay bonuses even under bankruptcy proceedings — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Keryx Biopharmaceuticals

Keryx Biopharmaceuticals

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    0
    Views:
    890
  2. anonymous
    Replies:
    9
    Views:
    2,409
  3. anonymous
    Replies:
    4
    Views:
    1,813
  4. Irate Shareholder
    Replies:
    9
    Views:
    2,811
  5. anonymous
    Replies:
    0
    Views:
    716
  6. anonymous
    Replies:
    8
    Views:
    1,986
  7. anonymous
    Replies:
    27
    Views:
    5,189
  8. anonymous
    Replies:
    20
    Views:
    6,161
  9. anonymous
    Replies:
    1
    Views:
    1,037
  10. anonymous
    Replies:
    4
    Views:
    1,202
  11. anonymous
    Replies:
    1
    Views:
    1,230
  12. anonymous
    Replies:
    23
    Views:
    6,856
  13. Angry Shareholder
    Replies:
    6
    Views:
    2,045
  14. anonymous
    Replies:
    6
    Views:
    4,326
  15. anonymous
    Replies:
    0
    Views:
    824
  16. anonymous
    Replies:
    203
    Views:
    29,888
  17. anonymous
    Replies:
    19
    Views:
    7,555
  18. anonymous
    Replies:
    177
    Views:
    43,171
  19. anonymous
    Replies:
    3
    Views:
    1,600
  20. anonymous
    Replies:
    7
    Views:
    1,625

Thread Display Options

Loading...